Human umbilical cord-derived mesenchymal stem cells do not undergo malignant transformation during long-term culturing in serum-free medium

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Chen, Gecai ^a   Yue, Aihuan ^b   Ruan, Zhongbao ^a   Yin, Yigang ^a   Wang, RuZhu ^a   Ren, Yin ^a   Zhu, Li ^a  

^a TAIZHOU PEOPLE S HOSPITAL   (China)

^b Jiangsu Beike Bio Technology Co Ltd   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; CARTILAGE CELL; CELL CULTURE; CELL DENSITY; CELL DIFFERENTIATION; CELL EXPANSION; CHROMOSOME LOSS; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; KARYOTYPING; MALE; MALIGNANT TRANSFORMATION; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OPTICAL DENSITY; OSTEOCYTE; CELL TRANSFORMATION; CULTURE MEDIUM; CYTOLOGY; FLOW CYTOMETRY; IMMUNOLOGY; MESENCHYMAL STROMA CELL; UMBILICAL CORD;

CULTURE MEDIUM;

CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; KARYOTYPING; MESENCHYMAL STROMAL CELLS; UMBILICAL CORD;

EID: 84902328883     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098565     Document Type: Article

References (31)

1. Wang L, Ott L, Seshareddy K, Weiss ML, Detamore MS (2011) Musculoskeletal tissue engineering with human umbilical cord mesenchymal stromal cells. Regen Med 6: 95-109. doi: 10.2217/rme.10.98
2. Arufe MC, De la Fuente A, Fuentes I, Toro FJ, Blanco FJ (2011) Umbilical cord as a mesenchymal stem cell source for treating joint pathologies. World J Orthop 2: 43-5
3. Akiyama K, You YO, Yamaza T, Chen C, Tang L, et al. (2012) Characterization of bone marrow derived mesenchymal stem cells in suspension. Stem Cell Res Ther 3: 40. doi: 10.1186/scrt131
4. Al-Nbaheen M, Vishnubalaji R, Ali D, Bouslimi A, Al-Jassir F, et al. (2013) Stromal (Mesenchymal) Stem Cells from Bone Marrow, Adipose Tissue and Skin Exhibit Differences in Molecular Phenotype and Differentiation Potential. Stem Cell Rev 9: 32-43. doi: 10.1007/s12015-012-9365-8
5. Patel DM, Shah J, Srivastava AS (2013) Therapeutic Potential of Mesenchymal Stem Cells in Regenerative Medicine. Stem Cells Int 2013: 496218. doi: 10.1155/2013/496218
6. Zhou YF, Bosch-Marce M, Okuyama H, Krishnamachary B, Kimura H, et al. (2006) Spontaneous Transformation of Cultured Mouse Bone Marrow-Derived Stromal Cells. Cancer Res 66:10849-10854; doi:10.1158/0008-5472.
7. Røsland GV1, Svendsen A, Torsvik A, Sobala E, McCormack E, et al. (2009) Long-term Cultures of Bone Marrow-Derived Human Mesenchymal Stem Cells Frequently Undergo Spontaneous Malignant Transformation. Cancer Res 69:5331-5339; doi:10.1158/0008-5472.
8. Luc Sensebé (2008) Clinical grade production of mesenchymal stem cells. BioMed Mater Eng 18: S3-S10
9. Zhang Y, Khan D, Delling J, Tobiasch E (2012) Mechanisms Underlying the Osteo- and Adipo-Differentiation of Human Mesenchymal Stem Cells. Scientific World Journal 2012: 793823. doi: 10.1100/2012/793823
10. Lansdorp P M (2008) Telomeres, stem cells and hematology. Blood 11: 1759-1766. doi: 10.1182/blood-2007-09-084913
11. Sekulovic S, Gylfadottir V, Vulto I, Gasparetto M, Even Y, et al. (2011) Prolonged self-renewal activity unmasks telomerase control of telomere homeostasis and function of mouse hematopoietic stem cells. Blood 118: 1766-1773.doi: 10.1182/blood-2010-11-319632
12. Forostyak S, Jendelova P, Sykova E (2013) The role of mesenchymal stromal cells in spinal cord injury, regenerative medicine and possible clinical applications. Biochimie 95:2257-70. doi: 10.1016/j.biochi.2013.08.004.
13. Li WW, Wei YH, Li H, Lai DM, Lin TN (2013) Isolation and characterization of a novel strain of mesenchymal stem cells from mouse umbilical cord: potential application in cell-based therapy. PLoS One 8:e74478. doi: 10.1371/journal.pone.0074478.
14. Troyer DL, Weiss ML (2008) WEISS Concise Review: Wharton's Jelly-Derived Cells Are a Primitive Stromal Cell Population. Stem Cells 26:591-599
15. Purandare B, Teklemariam T, Zhao L, Hantash BM (2014) Temporal HLA profiling and immunomodulatory effects of human adult bone marrow- and adipose-derived mesenchymal stem cells. Regen Med 9:67-79. doi:10.2217/rme.13. 82.17.
16. Herberts CA, Kwa MS, Hermsen HP (2011)Risk factors in the development of stem cell therapy. J Transl Med 9:29. doi: 10.1186/1479-5876-9-29.
17. Binato R, de Souza Fernandez T, Lazzarotto-Silva C, Du Rocher B, Mencalha A, et al. (2013) Stability of human mesenchymal stem cells during in vitro culture: considerations for cell therapy. Cell Prolif 46:10-22. doi: 10.1111/cpr.12002.
18. Aguilar S, Nye E, Chan J, Loebinger M, Spencer-Dene B, et al. (2007) Murine but not human mesenchymal stem cells generate osteosarcoma-like lesions in the lung. Stem Cells 25:1586-1594 (Pubitemid 47106029)
19. Tolar J, Nauta AJ, Osborn MJ, Panoskaltsis Mortari A, McElmurry RT, et al. (2007) Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 25:371-379 (Pubitemid 46232791)
20. Sarugaser R, Lickorish D, Baksh D (2005) Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells 23: 220-229 (Pubitemid 40239517)
21. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, et al. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement International Society for Cellular Therapy. Cytotherapy 8: 315-317 (Pubitemid 44269669)
22. Ahrari I, Purhabibi Zarandi N, Khosravi Maharlooei M, Monabati A, Attari A, et al. (2013) Adipose Tissue Derived Multipotent Mesenchymal Stromal Cells Can Be Isolated Using Serum-free Media. Iran Red Crescent Med J 15:324-9 doi: 10.5812/ircmj.4506
23. Patrikoski M, Juntunen M, Boucher S, Campbell A, Vemuri MC, et al. (2013) Development of fully defined xeno-free culture system for the preparation and propagation of cell therapy-compliant human adipose stem cells. Stem Cell Res Ther 4: 27.
24. Hartmann I, Hollweck T, Haffner S, Krebs M, Meiser B, et al. (2010) Umbilical cord tissue-derived mesenchymal stem cells grow best under GMP-compliant culture conditions and maintain their phenotypic and functional properties. J Immunol Methods 363:80-9. doi: 10.1016/j.jim.2010.10.008.
25. Redaelli S, Bentivegna A, Foudah D, Miloso M, Redondo J, et al. (2012) From cytogenomic to epigenomic profiles: monitoring the biological behavior ofin vitro cultured human bone marrow mesenchymal stem cells. Stem Cell Research & Therapy 3:47 doi:10.1186/scrt138
26. Bernardo ME, Zaffaroni N, Novara F, Cometa AM, Avanzini MA, et al. (2007) Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res 67:9142-9149 (Pubitemid 47535900)
27. Tang Q, Chen Q, Lai X, Liu S, Chen Y, et al. (2013) Malignant Transformation Potentials of Human Umbilical Cord Mesenchymal Stem Cells Both Spontaneously and via 3-Methycholanthrene Induction. PLoS One. 8:e81844. doi: 10.1371/journal. pone.0081844.
28. Torsvik A, Røsland GV, Svendsen A, Molven A, Immervoll H, et al. (2010) Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination:putting the research field on track - letter. Cancer Res 70:6393-6. doi: 10.1158/0008-5472.
29. Torsvik A, Røsland GV, Bjerkvig R (2012) Comment to:"Spontaneous transformation of adult mesenchymal stem cells from cynomolgus macaques invitro" byZ.Renetal.Exp.CellRes.317(2011)2950-2957: spontaneous transformation of mesenchymal stemcells in culture: facts or fiction? Exp Cell Res 318:441-3. doi: 10.1016/j.yexcr.2011.12.009.
30. Torsvik A, Røsland GV, Bjerkvig R (2012) Spontaneous transformation of stem cells in vitro and the issue of cross-contamination. Int J Biol Sci 8:1051-2; discussion 1053-4. doi: 10.7150/ijbs.3665.
31. Røsland GV, Svendsen A, Torsvik A, Sobala E, McCormack E, et al. (2009) Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneousmalignant transformation. Cancer Res 69:5331-9. doi: 10.1158/0008-5472.